Oncoinvent AS is looking to strengthen its team by hiring a Clinical Study Manager at its offices in Oslo, Norway. The position presents a unique opportunity to join an expanding biotechnology start-up that is about to initiate the first-in-human/phase I studies for the lead product candidate, Radspherin®. Radspherin® is a radiopharmaceutical targeting to treat peritoneal carcinomatosis.
The candidates should be looking for the energy and enthusiasm in a start-up company with the ambition to make a difference. Successful candidates should be flexible, team-oriented yet able to work independent, analytical and results oriented.
For more information, please contact external recruiter, Borka Consulting:
Cecilie Borka at +47 928 55 352 or André Borka at +47 908 31 871. Please send your application (both motivational letter and CV) in PDF format to firstname.lastname@example.org. Interviews are held consecutively, please show your interest as soon as possible!
+47 464 40 045
Jan A. Alfheim is a business executive with over thirty years’ experience bringing product ideas and technology to the chemical and pharmaceutical markets, from product concept inception through discovery and development phases to final marketing campaign and launch.
With experience in research, project management, business development & partnering, company start-ups, and product launches, Alfheim comes from Nordic Nanovector ASA where he was Chief Executive Officer from 2011 until 2014 and Chief Operating Officer from 2014 to 2016. Prior to working at Nordic Nanovector, he has held various senior roles including Chief Business Officer at Clavis Pharma, President of StemPath Inc, Director of Business Development at Neurochem Inc and Project Director at Nycomed Imaging. Mr. Alfheim holds a MSc from Concordia University and a MBA from McGill University.